Whetstone Capital Advisors LLC Invests $7.72 Million in Health Catalyst, Inc. $HCAT

Key Points

• Whetstone Capital Advisors LLC invested approximately $7.72 million to acquire 1,705,072 shares of Health Catalyst, Inc., making it the firm's 10th largest holding.
• Several hedge funds have also increased their stakes in Health Catalyst, with institutional investors owning about 85% of the stock.
• The stock has received mixed ratings from analysts, with target prices decreasing recently, reflecting a consensus average target of $6.18 and a majority rating of "Hold."

Whetstone Capital Advisors LLC acquired a new position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,705,072 shares of the company's stock, valued at approximately $7,724,000. Health Catalyst comprises about 3.4% of Whetstone Capital Advisors LLC's portfolio, making the stock its 10th largest holding. Whetstone Capital Advisors LLC owned approximately 2.43% of Health Catalyst as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Group One Trading LLC lifted its holdings in shares of Health Catalyst by 107.6% during the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock worth $31,000 after acquiring an additional 2,260 shares during the last quarter. XTX Topco Ltd bought a new stake in shares of Health Catalyst during the 1st quarter worth $54,000. Aquatic Capital Management LLC bought a new stake in shares of Health Catalyst during the 4th quarter worth $63,000. Brevan Howard Capital Management LP purchased a new position in Health Catalyst in the 4th quarter worth $92,000. Finally, Jump Financial LLC purchased a new position in Health Catalyst in the 4th quarter worth $112,000. 85.00% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on HCAT shares. Stifel Nicolaus decreased their target price on shares of Health Catalyst from $5.50 to $4.50 and set a "hold" rating on the stock in a research report on Friday, August 8th. Evercore ISI decreased their target price on shares of Health Catalyst from $5.00 to $4.00 and set an "in-line" rating on the stock in a research report on Wednesday, July 9th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $4.00 target price (down previously from $9.00) on shares of Health Catalyst in a research report on Friday, August 8th. Citigroup cut shares of Health Catalyst from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $6.50 to $3.50 in a research report on Friday, August 8th. Finally, BTIG Research cut shares of Health Catalyst from a "buy" rating to a "neutral" rating in a research report on Tuesday, June 17th. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $6.18.

Health Catalyst Price Performance

HCAT stock opened at $2.92 on Thursday. The firm's 50-day moving average price is $3.68 and its two-hundred day moving average price is $4.12. Health Catalyst, Inc. has a 12-month low of $2.52 and a 12-month high of $9.24. The stock has a market capitalization of $205.48 million, a price-to-earnings ratio of -1.93 and a beta of 1.46. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

Want to see what other hedge funds are holding HCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Health Catalyst, Inc. (NASDAQ:HCAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.